H&E staining (Fig. 3b) along with quantification of human HPRT mRNA expression (Fig. 3e) confirmed that co-injection with KRAS-Mφ or siMOCK-Mφ could lead to a significant increase in the tumor burden of liver metastasis. This evidence concerns the gene KRAS and neoplasm.